Catalyst Biosciences (CBIO) Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ANT
3. SPY
4. FFR
5. FFAI
6. TSLA
7. META
8. FICO
9. CART
10. LLY

Go back to Catalyst Biosciences (CBIO) Provides Corporate Update

Catalyst Biosciences Provides Corporate Update

February 28, 2023 8:00 AM EST

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Catalyst Biosciences Inc. (NASDAQ: CBIO) (Catalyst or the Company) today provided two corporate updates.

In connection with the Companys previously announced asset purchase agreement with GNI Group Ltd (GNI Group) and GNI Hong Kong Limited (together GNI) to purchase all of the assets and intellectual property rights primarily related to GNIs proprietary hydronidone compound outside of China (collectively, the F351 Assets), and the definitive agreement with GNI and other minority stockholders to purchase their controlling interest in Beijing Continent Pharmaceutical Co. Ltd., a commercial-stage pharmaceutical company... More